Stock Market Movers: Goldman Sachs, Apple, Pfizer, and Intel Updates

Goldman Sachs' Strong Quarter

• 📈 Goldman Sachs shares rose significantly, driven by reporting their highest quarterly revenue haul on record for equities trading.
• 💰 The bank announced a substantial share buyback program of up to $40 billion, following a record year in 2024.
• 💬 CEO David Solomon expressed confidence in the firm's ability to support clients despite a changing operating environment.

Apple and Tariff Exemptions

• 🍎 Apple shares saw a jump, benefiting from news that the White House was temporarily exempting some tech products from tariffs.
• 🚚 While President Trump later clarified that exemptions were temporary and moving to different tariff buckets, the initial news boosted Apple and other tech companies.
• 🌐 This positive sentiment extended to companies like Dell, HP, and the chip sector, including Nvidia, AMD, Broadcom, and Qualcomm, as well as Apple suppliers like Foxconn.

Pfizer's Obesity Pill Setback

• 💊 Pfizer announced it is stopping development of its closely watched obesity pill, danuglipron, due to a potential drug-related liver injury in a clinical trial patient.
• 📉 This news caused Pfizer's shares to fall, as they were already facing competition in the obesity market.
• 🚀 Pfizer's setback is benefiting competitors such as Novo Nordisk and Eli Lilly, whose shares saw increases.

Intel's Strategic Sale

• ⚙️ Intel shares rose on news of a strategic sale: agreeing to sell a 51% stake in its programmable chips unit, Altera, to Silver Lake Management.
• 💲 The deal values Altera at $8.75 billion, though Intel had originally paid approximately $17 billion for the company in 2015.
• 🎯 This move is part of Intel's strategy to spin off non-essential businesses as it navigates market challenges, including losing market share and missing the AI accelerator market shift.